Industry News
Surveillance Best Follow-Up Strategy Among Men With Stage I Seminoma
May 17, 2013
A long-term study of men with stage I seminoma, a common form of testicular cancer, suggests that surveillance for cancer recurrence, rather than additional chemotherapy or radiation therapy, is sufficient for the vast majority of patients who have undergone successful surgery for their cancer... Read More
Exercise Lowers Risk Of Lung And Colorectal Cancer Among Middle Aged Men
May 17, 2013
New research conducted by researchers at the University of Vermont reveals that middle-aged men who engage in a lot of cardiovascular exercise are at a reduced risk of suffering from lung and colorectal cancer. In addition, those who exercise are less likely to die from prostate cancer (although their risk of contracting the disease remained the same)... Read More
Molecular Profiling Timely For Tailoring Cancer Therapy
May 17, 2013
A clinical trial has shown that patients, and their physicians, are eager to jump into next-era cancer care - analysis of an individual's tumor to find and target genetic mutations that drive the cancer. Results of the study, CUSTOM, are being presented at the 2013 annual meeting of the American Society of Clinical Oncology* years before investigators thought they would be ready... Read More
Blocking The Protein-Protein Interaction Which Causes Ewing Sarcoma
May 17, 2013
Continuous infusion of a novel agent not only halted the progression of Ewing sarcoma in rats, while some tumors also regressed to the point that cancer cells could not be detected microscopically, say researchers at Georgetown Lombardi Comprehensive Cancer Center... Read More
Bankruptcy An Increased Risk Following Cancer Diagnosis
May 17, 2013
People diagnosed with cancer are more than two-and-a-half times more likely to declare bankruptcy than those without cancer, according to a new study from Fred Hutchinson Cancer Research Center... Read More
Androgen Deprivation Therapy For Prostate Cancer Can Cause Osteoporosis
May 16, 2013
Androgen deprivation therapy is a common and effective treatment for advanced prostate cancer. However, among other side-effects, it can cause significant bone thinning in men on long-term treatment... Read More
In Preclinical Studies, New Drug Enhances Radiation Treatment For Brain Cancer
May 16, 2013
A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse models of human glioblastoma multiforme (GBM), the new drug helped significantly extend survival when used in combination with radiation therapy... Read More
Study Findings May Offer New Way To Kill Cancer Cells By Forcing Them Into An Alternative Programmed Death Pathway
May 16, 2013
When cells suffer too much DNA damage, they are usually forced to undergo programmed cell death, or apoptosis. However, cancer cells often ignore these signals, flourishing even after chemotherapy drugs have ravaged their DNA... Read More
Chemists Demonstrate Nanoscale Alloys So Bright They Could Have Potential Medical Applications
May 16, 2013
Alloys like bronze and steel have been transformational for centuries, yielding top-of-the-line machines necessary for industry. As scientists move toward nanotechnology, however, the focus has shifted toward creating alloys at the nanometer scale - producing materials with properties unlike their predecessors... Read More
FDA Approves New Lung Cancer Diagnostic "Cobas EGFR Mutation Test"
May 15, 2013
The U.S. Food and Drug Administration (FDA) has approved the cobas EGFR Mutation Test, a companion diagnostic for the cancer drug Tarceva (erlotinib). This is the first FDA-approved companion diagnostic that detects epidermal growth factor receptor (EGFR) gene mutations, which are present in approximately 10 percent of non-small cell lung cancers (NSCLC)... Read More
Previous Page Next Page